Brogden, Kim A.
Parashar, Deepak
Hallier, Andrea R.
Braun, Terry
Qian, Fang
Rizvi, Naiyer A.
Bossler, Aaron D.
Milhem, Mohammed M.
Chan, Timothy A.
Abbasi, Taher
Vali, Shireen
Funding for this research was provided by:
National Institutes of Health (R01 DE014390)
Article History
Received: 21 April 2017
Accepted: 15 February 2018
First Online: 27 February 2018
Change Date: 12 April 2018
Change Type: Correction
Change Details: It has been highlighted that in the original manuscript [1] Table S3 ‘An example of the predictive computational modeling process. Specific details on an annexure section of the PD-L1 pathway show the step-by-step reactions, mechanisms, and reaction equations that occur. Such reactions also occurred in all of the other pathways’ was omitted and did not appear in the Additional files and that the Additional files were miss-numbered thereafter. This Correction shows the correct and incorrect Additional files. The original article has been updated.
Ethics approval and consent to participate
: All patients had stage IV non-small cell lung cancer (NSCLC) and were treated at Memorial Sloan Kettering Cancer Center (<i>n</i> = 29) or the University of California at Los Angeles (<i>n</i> = 5) on protocol NCT01295827. All patients had consented to the Memorial Sloan Kettering Cancer Center Institutional Review Board-approved protocols permitting tissue collection and sequencing.All patient related research was Memorial Sloan Kettering Cancer Center Institutional Review Board-approved and treated under protocol NCT0129827. Written informed consent was obtained from all patients.
: Not applicable.
: KAB has had a Cooperative Research and Development Agreement with Cellworks Group Inc., San Jose, CA. TA and SV work for Cellworks Group Inc., San Jose, California. DP, NKS, and UM work for Cellworks Research India Ltd., Whitefield, Bangalore, India. TAC is a co-founder of Gritstone Oncology and holds equity in the company. All other authors declare no competing financial interests in the findings of this study or with Cellworks Group Inc., San Jose, CA or Cellworks Research India Ltd., Whitefield, Bangalore, India.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.